Brookfield Corp’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-3,460
Closed -$988K – 559
2023
Q2
$988K Sell
3,460
-7,591
-69% -$2.11M ﹤0.01% 466
2023
Q1
$2.4M Buy
11,051
+2,418
+28% +$471K 0.01% 401
2022
Q4
$1.78M Buy
8,633
+4,380
+103% +$1.11M 0.01% 429
2022
Q3
$1.18M Sell
4,253
-1,172
-22% -$298K ﹤0.01% 518
2022
Q2
$1.04M Sell
5,425
-4,339
-44% -$766K ﹤0.01% 500
2022
Q1
$2.02M Buy
+9,764
New +$1.61M 0.01% 397

Other funds holding SWAV

Brookfield Corp's SWAV Position: Q3 2023 in Review

Brookfield Corp sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 3,460 shares — an estimated $988K sold.

Brookfield Corp first reported a position in SWAV in Q1 2022 and held it in 6 quarters. The position peaked at $2.4M in Q1 2023. 411 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Brookfield Corp reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 3,460 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $988K.
  • Brookfield Corp first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Brookfield Corp's Shockwave Medical, Inc. Common Stock position peaked at $2.4M in Q1 2023.
  • 411 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.